Retrospective Side Effect Profiling of the Metastatic Melanoma Combination Therapy Ipilimumab-Nivolumab Using Adverse Event Data

Recent studies suggest that combining nivolumab with ipilimumab is a more effective treatment for melanoma patients, compared to using ipilimumab or nivolumab alone. However, treatment with these immunotherapeutic agents is frequently associated with increased risk of toxicity, and (auto-) immune-re...

Descripción completa

Detalles Bibliográficos
Autores principales: Soldatos, Theodoros G., Dimitrakopoulou-Strauss, Antonia, Larribere, Lionel, Hassel, Jessica C., Sachpekidis, Christos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316083/
https://www.ncbi.nlm.nih.gov/pubmed/30384507
http://dx.doi.org/10.3390/diagnostics8040076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316083/
https://www.ncbi.nlm.nih.gov/pubmed/30384507
http://dx.doi.org/10.3390/diagnostics8040076

Ejemplares similares